Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

776
1
Whitehawk Therapeutics, Inc. Whitehawk Therapeutics Reports $63.7M Net Loss for 2024, Increases Revenue from FYARRO

Via official filing (AI summary) | 23 days ago | 0 comments

777
1
BioAtla, Inc. BioAtla Reports $69.7 Million Net Loss for Fiscal Year 2024, Highlights Strategic Improvements

Via official filing (AI summary) | 23 days ago | 0 comments

778
1
PROVECTUS BIOPHARMACEUTICALS, INC. Provectus Biopharmaceuticals Reports $4.76 Million Net Loss and Revenue Growth Amid Financial Challenges

Via official filing (AI summary) | 23 days ago | 0 comments

779
1
My Size, Inc. My Size, Inc. Reports 18.1% Revenue Growth to $8.26 Million, Despite Net Loss Reduction

Via official filing (AI summary) | 24 days ago | 0 comments

780
1
Sharps Technology Inc. Sharps Technology Reports $9.3 Million Net Loss for Fiscal Year 2024, Focuses on Product Expansion

Via official filing (AI summary) | 24 days ago | 0 comments

781
1
Aspira Women's Health Inc. Aspira Women's Health Reports $13.1 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

782
1
DURECT CORP DURECT Corporation Reports $8.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

783
1
Synaptogenix, Inc. Synaptogenix Reports Increased Net Losses of $12.8 Million for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

784
1
American Oncology Network, Inc. American Oncology Network Reports 37.5% Revenue Growth to $1.76 Billion for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

785
1
HireQuest, Inc. HireQuest Reports $34.6 Million Revenue for Fiscal Year 2024, Down 8.7%

Via official filing (AI summary) | 24 days ago | 0 comments

786
1
SeaStar Medical Holding Corp SeaStar Medical Reports $24.8 Million Net Loss, First Revenue from QUELIMMUNE Sales

Via official filing (AI summary) | 24 days ago | 0 comments

787
1
IZEA Worldwide, Inc. IZEA Worldwide Reports $35.9M Revenue and $18.9M Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

788
1
Cingulate Inc. Cingulate Inc. Reports $15.5 Million Net Loss for Fiscal Year 2024, Down from $23.5 Million

Via official filing (AI summary) | 24 days ago | 0 comments

789
1
Stardust Power Inc. Stardust Power Inc. Reports $23.75 Million Net Loss Following Business Combination and Lithium Refinery Development

Via official filing (AI summary) | 24 days ago | 0 comments

790
1
M-tron Industries, Inc. M-tron Industries Reports 19.1% Revenue Growth to $49.0 Million for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

791
1
TMC the metals Co Inc. TMC Reports $81.9 Million Net Loss for Fiscal Year 2024, Highlights Key Developments

Via official filing (AI summary) | 24 days ago | 0 comments

792
1
Gevo, Inc. Gevo Reports $78.6 Million Net Loss for Fiscal Year 2024, Acquires Red Trail Energy

Via official filing (AI summary) | 24 days ago | 0 comments

793
1
Dolphin Entertainment, Inc. Dolphin Entertainment Reports $51.7 Million Revenue for Fiscal Year 2024, Net Loss Improves

Via official filing (AI summary) | 24 days ago | 0 comments

794
1
Channel Therapeutics Corp Chromocell Therapeutics Reports $7.96 Million Net Loss for 2024, Completes IPO and Merger

Via official filing (AI summary) | 24 days ago | 0 comments

795
1
Lulu's Fashion Lounge Holdings, Inc. Lulu's Fashion Lounge Reports 11% Revenue Decline and $55.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

796
1
U.S. GoldMining Inc. U.S. GoldMining Reports $8.5 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments

797
1
CV Sciences, Inc. CV Sciences Reports Slight Decline in Sales, Strategic Acquisitions and New Product Launches

Via official filing (AI summary) | 24 days ago | 0 comments

798
1
ASPAC II Acquisition Corp. ASPAC II Acquisition Corp. Reports Significant Net Income Decline and Faces Delisting Challenges

Via official filing (AI summary) | 24 days ago | 0 comments

799
1
bluebird bio, Inc. bluebird bio Reports Revenue Growth to $83.8 Million Amid Increased Gene Therapy Infusions

Via official filing (AI summary) | 24 days ago | 0 comments

800
1
TherapeuticsMD, Inc. TherapeuticsMD Reports Improved Net Loss and Increased License Revenue for Fiscal Year 2024

Via official filing (AI summary) | 24 days ago | 0 comments